The Company of Pharmaceutical Industries of Tunisia (SIPHAT) said it has achieved a turnover increase of 2% in the first half of the year, compared to the previous year to 16.7 million dinars representing 34% of the expected turnover in the 2018 projected budget.
The export turnover achieved in the first half of 2018 (0.325 MD) has increased by 200% compared to the same period of 2017.
As for the value of production, it rose from 14.7 million dinars in the first half of 2017 to 16.1 million for the same period of 2018, an increase of 9%.
SIPHAT’s indebtedness dropped from 36.9 MD at December 31, 2017 to 32.7 MD in the first half of 2018, thus recording a decrease of 11%.
On the human resources side, the number of employees has decreased from 574 employees on June 30, 2017 to 542 employees as of June 30, 2018.